Aemetis ( NASDAQ:AMTX – Get Free Report ) posted its earnings results on Thursday. The specialty chemicals company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.18, FiscalAI reports. The firm had revenue of $88.15 million during the quarter, compared to analyst estimates of $74.20 million.
Here are the key takeaways from Aemetis’ conference call:
Get Aemetis alerts:
Third-quarter results improved sharply: revenue rose 49% year over year to $88.2 million, net income was $5.2 million, and Adjusted EBITDA reached $24.8 million, versus a loss in both measures a year earlier. Results included $24.7 million in 45Z tax-credit revenue, including an $11 million catch-up adjustment, so reported performance was partly driven by credits.
Aemetis said seven dairy RNG pathways averaging a carbon-intensity score of negative 380 are approved, with six more pending, supporting greater LCFS credit generation. The company also reported 14 operating digesters and said production has exceeded its forecasts, though further growth depends in part on new pathway approvals and financing.
The Keyes ethanol plant’s MVR project is expected by management t...